Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Achiko AG's share price for the quarter that ended in Jun. 2022 was $0.05. Achiko AG's Shares Outstanding (EOP) for the quarter that ended in Jun. 2022 was 132.65 Mil. Therefore, Achiko AG's market cap for the quarter that ended in Jun. 2022 was $6.63 Mil.
Achiko AG's quarterly market cap
increased
from Jun. 2021 ($27.95 Mil) to Dec. 2021 ($32.02 Mil) but then
declined
from Dec. 2021 ($32.02 Mil) to Jun. 2022 ($6.63 Mil).
Achiko AG's annual market cap
stayed the same
from Dec. 2019 ($0.00 Mil) to Dec. 2020 ($0.00 Mil) but then
increased
from Dec. 2020 ($0.00 Mil) to Dec. 2021 ($32.02 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Achiko AG's Enterprise Value for Today is $4.47 Mil.
Achiko AG Market Cap Historical Data
The historical data trend for Achiko AG's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Health Information Services subindustry, Achiko AG's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Achiko AG's Market Cap Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Achiko AG's Market Cap distribution charts can be found below:
* The bar in red indicates where Achiko AG's Market Cap falls into.
Achiko AG Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Achiko AG's Market Cap for the fiscal year that ended in Dec. 2021 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Achiko AG (OTCPK:ACHKF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Achiko AG Market Cap Related Terms
Thank you for viewing the detailed overview of Achiko AG's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Achiko AG is developing disruptive diagnostic solutions that put people first. The company product is a rapid, reliable Covid-19 test with a companion app offering a user-friendly digital health passport. Achiko creates and develops aptamer-based diagnostics through its biotechnology division, AptameX, and companion health apps via its digital mobile health technology division, Teman Sehat. The AptameX DNA aptamer tests can be rapidly chemically synthesized, are cost-effective, and have wide potential across multiple disease diagnostics. Leveraging AptameX and Teman Sehat, Achiko aims to deliver fast, accurate, and affordable diagnostic testing for a range of pathogenic diseases and therapeutic indications in the rapidly evolving healthcare diagnostics field.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ACHKF has been successfully added to your